NovaBridge Biosciences (NBP)
NASDAQ: NBP · Real-Time Price · USD
2.670
+0.070 (2.69%)
At close: Apr 16, 2026, 4:00 PM EDT
2.660
-0.010 (-0.37%)
After-hours: Apr 16, 2026, 4:48 PM EDT
NovaBridge Biosciences Market Cap
NovaBridge Biosciences has a market cap or net worth of $308.78 million as of April 16, 2026. Its market cap has increased by 360.22% in one year.
Market Cap
308.78M
Enterprise Value
101.01M
1-Year Change
360.22%
Ranking
Category
Stock Price
$2.67
Market Cap Chart
Since January 17, 2020, NovaBridge Biosciences's market cap has increased from $138.05M to $308.78M, an increase of 123.68%. That is a compound annual growth rate of 13.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 300.69M | -34.47% |
| Dec 31, 2025 | 458.86M | 562.90% |
| Dec 31, 2024 | 69.22M | -56.10% |
| Dec 29, 2023 | 157.68M | -54.60% |
| Dec 30, 2022 | 347.35M | -90.48% |
| Dec 31, 2021 | 3.65B | 9.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AC Immune | 311.49M |
| Abeona Therapeutics | 308.06M |
| Polaryx Therapeutics | 305.84M |
| Inhibikase Therapeutics | 305.06M |
| Cellectis | 304.73M |
| Avalo Therapeutics | 304.23M |
| LENZ Therapeutics | 300.38M |
| Anavex Life Sciences | 300.26M |